Altogether, this may explain why clinical biomarkers such as CRP and D-dimer are good predictors of COVID-19-associated disease progression and complications, since these proteins are rapidly secreted in response to infections within hours, as part of establishing a systemic inflammatory state to trigger host immune response [55, 56]. The gene discussed is CRP; the disease is COVID-19.